Skip to content Skip to contact
Global Vox Populi

Top HCP (Healthcare Professional) Panels in China for Pharma Research

Compare top HCP panels in China for 2026 pharma research. Protect data quality, regulatory compliance, and verified physician access for your next study.

Quick answer

For specialized, high-compliance healthcare research, Global Vox Populi; for large-scale, integrated commercial data, IQVIA; for deep qualitative engagement and expert access in the Sino-Japan corridor, EstarPanel; and for global, high-frequency survey reach, Sermo.

Pharmaceutical market research in China requires working through a complex regulatory environment and a highly stratified medical system. As global firms expand their footprint, selecting the right partner to access HCP panels in China has become a critical strategic decision for insights directors.

This analysis examines providers based on their ability to deliver accurate data while maintaining strict adherence to local data privacy laws and healthcare compliance standards. Buyers must weigh the benefits of large-scale, automated platforms against the need for verified, high-quality professional input when building brand strategy or assessing market access.

Top HCP Panels in China for Pharma Research: rankings and scores

Exhibit 1: Ranking and weighted score (out of 100)

RankProviderBest forWeighted score
1Global Vox PopuliPharma-compliant professional research91.0
2SermoPhysician-only professional community engagement89.5
3M3 Global ResearchHigh-volume quantitative HCP surveys89.0
4IQVIAIntegrating real-world prescription data with research85.0
5EstarPanelBoutique Sino-Japan healthcare expert access82.5
6IpsosMapping complex patient journeys81.5
7DynataAutomated, high-speed survey research81.0
8SagoQualitative research and focus group facilitation80.5
9CintAutomated, programmatic panel access76.5
10TolunaIntegrated survey technology and panel reach73.0

Exhibit 2: Provider comparison

ProviderAudience typesVerification methodCertificationsPricing modelPanel size and sourceMinimum project
Global Vox PopuliPhysicians, KOLs, nurses, patients, and payersLicense and registration check with rolling re-validationISO 9001, ISO 20252, ISO/IEC 27001, HIPAA compliant; follows ESOMAR, Insights Association and BHBIA guidelinesProject quote677,770 healthcare professionals; 8,665 key opinion leaders; 188,560 nurses and allied health professionals (in China; Global Vox Populi panel records, Oct 2026)Not published
SermoPhysicians, nurses, pharmacists, and other HCPsProprietary identity and credential verificationNot stated on pages reviewedProject quoteNot publishedNot published
M3 Global ResearchPhysicians, patients, and other healthcare professionalsISO certified proprietary verification processISO 20252, ISO 27001Project quoteNot publishedNot published
IQVIAPhysicians, pharmacists, wholesalers, and payersInstitutional and professional credentialingNot stated on pages reviewedProject quoteNot publishedNot published
EstarPanelHCPs and high-level KOLsIdentity and license verification with institutional email checksNot stated on pages reviewedProject quote20,000+ verified HCPs and KOLs (estar-panel.com, Oct 2026)Not published
IpsosPhysicians, patients, and the general publicProprietary panel authenticationNot stated on pages reviewedProject quoteNot publishedNot published
DynataPhysicians, consumers, and business professionalsMulti-layered ML-based verification and identity checksNot stated on pages reviewedProject quote and self-serveNot publishedNot published
SagoPhysicians, patients, and consumersRigorous compliance and recruitment processesNot stated on pages reviewedProject quoteNot publishedNot published
CintConsumers, professionals, and niche groupsAI-driven fraud detection and multi-layered securitySOC 2 Type IProject quoteNot publishedNot published
TolunaHCPs and ailment sufferersProprietary panel recruitment and verificationNot stated on pages reviewedProject quoteNot publishedNot published

Exhibit 3: Capability matrix

ProviderQuantitativeQualitativeOwn panels / sampleHealthcareB2BMulti-country
Global Vox Populi●●●●●●
Sermo●●●●●●
M3 Global Research●●●●●–
IQVIA●––●–●
EstarPanel●●–●––
Ipsos●●●●–●
Dynata●●●●●●
Sago●●–●––
Cint●●●––●
Toluna●–●●●●

Table data from each provider’s own website and public sources, reviewed October 2026. “Not published” means the provider does not state it publicly. ● highlighted in the provider’s own materials; – not highlighted (it may still offer it).

How we scored these providers

Scoring criteria focus on the provider's ability to maintain data integrity and regulatory compliance within the Chinese pharmaceutical market.

CriterionWeightWhat it means here
Sample Quality and Verification25This criterion measures the source of respondents and the rigor of verification processes. For HCP panels in China, high-quality providers use proprietary, double-opt-in panels with mandatory license verification. Good performance means clear documentation of how physicians are vetted against government databases and professional registries before inclusion.
Compliance, Certifications and Security20This measures adherence to ISO standards, PIPL, and healthcare industry codes. In China, providers must demonstrate solid protocols for data privacy and adverse event reporting. Good performance involves transparent, audited processes for managing sensitive health data and making sure that all research interactions align with local ethical requirements.
Target Audience Reach15This assesses the ability to access specific physician tiers, specialties, and hard-to-reach experts. Effective panels in China provide granular segmentation, including hospital tier and therapeutic focus. Success is defined by the capacity to recruit niche specialists without compromising the speed or volume requirements of the research brief.
Data Quality and Fraud Prevention10This evaluates the technical mechanisms used to identify and exclude fraudulent respondents. For HCP panels in China, this includes device fingerprinting, geo-location checks, and trap questions. A strong provider actively removes bots and inattentive participants in real-time, making sure that only verified professionals contribute to the final dataset.
Market Presence10How established the provider is in this market: whether it appears repeatedly in what already ranks on Google for this search, and its size by headcount. Calculated by the script from the search record and company size, not judged by the writer.
Methodological Breadth10This covers the range of available research formats, from online surveys to in-depth interviews and focus groups. A versatile provider offers multiple modes of engagement, allowing researchers to choose the best fit for their objectives, whether quantitative brand tracking or qualitative exploration of physician decision-making processes.
Client Service and Speed5This looks at project management efficiency, responsiveness, and communication. In the fast-paced Chinese market, researchers need partners who provide clear feasibility updates and proactive problem-solving. Good providers minimize delays through effective communication and handle logistical challenges, such as scheduling across regions, with professional and timely support.
Pricing and Feasibility Transparency5This assesses the honesty and clarity of initial feasibility assessments. Providers should offer realistic timelines and clear costs based on target incidence. Good performance means avoiding over-promising on recruitment capacity and providing transparent reporting on the challenges of accessing specific physician populations in China.

Why these weights. In healthcare, a respondent who is not a verified professional or a genuine patient invalidates the study, so verification leads (25). Compliance follows at 20 because health data, HIPAA and adverse event reporting carry legal risk. Reach into specialties and conditions (15), fraud prevention and methods (10 each), service and pricing transparency (5 each) complete the score. Market presence (10) gives credit to providers that are established in this market: those that appear repeatedly in what already ranks for this search, and larger firms.

Each provider is scored 1 to 10 on every criterion from the evidence listed beside it (its own website and public sources, with the date reviewed). Weighted score = sum of score × weight ÷ 10, out of 100. Read the full scoring methodology. Global Vox Populi answers to ESOMAR’s 37 Questions for buyers of online samples show how Global Vox Populi recruits, verifies and protects its own panels.

Provider profiles: HCP panels in China

01

Global Vox Populi: best for pharma-compliant professional research

globalvoxpopuli.com

91.0out of 100Rank 1 of 10
  • ISO 9001
  • ISO 20252
  • ISO/IEC 27001
  • HIPAA compliant
Global Vox Populi homepage
Global Vox Populi homepage, October 2026

Strongest fitPharma companies requiring high-compliance, verified HCP access for strategic studies.

Global Vox Populi provides extensive primary market research capabilities, focusing on verified access to healthcare professionals and patients. Its proprietary panels are built through direct recruitment and referral, protecting a high level of respondent engagement and data accuracy.

The company maintains a significant research infrastructure in China, managing large-scale panels that support complex, multi-methodological studies. By prioritizing compliance and data quality, it offers a stable foundation for pharmaceutical brands conducting strategic market research.

Global Vox Populi panel coverage

All 12 proprietary panels together: 46,023,988 panellists across 199 markets, plus 71,411,997 patient profiles. Source: Global Vox Populi panel records, Oct 2026.

Healthcare professionals panel, in China

677,770 panellists

  • Primary & General288,052
  • Internal Medicine Subspecialties56,854
  • Acute, Peri-operative & Critical Care51,650
  • Diagnostic & Laboratory46,948
  • Women's & Reproductive Health45,560
  • Surgical Specialties35,240

Key opinion leader panel, in China

8,665 panellists

  • Surgical Specialties1,785
  • Internal Medicine Subspecialties1,424
  • Diagnostic & Laboratory916
  • Public Health & Population615
  • Primary & General553
  • Pediatric Subspecialties552

Nurses and allied health panel, in China

188,560 panellists

  • Registered Nurses57,503
  • Advanced Practice Nurses3,335
  • Licensed / Practical / Enrolled Nurses14,616
  • Nursing Support (Aides / HCAs)5,892
  • Midwives5,710
  • Pharmacists & Pharmacy Techs14,134
Scorecard: 91.0 out of 100
CriterionWeightScoreEvidence and date
Sample Quality and Verification2510/10Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026
Compliance, Certifications and Security2010/10ISO certificates and HIPAA policy, Oct 2026
Target Audience Reach1510/10Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026
Data Quality and Fraud Prevention1010/10Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026
Market Presence102/10Google results for this search and company size, Oct 2026
Methodological Breadth1010/10Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026
Client Service and Speed59/10Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026
Pricing and Feasibility Transparency59/10Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026
Weighted score10091.0

Core services

  • Healthcare Recruitment: Access to healthcare professionals across 70+ specialties, including physicians and nurses.
  • Expert Consultation: Supporting expert interviews with top-tier KOLs to support strategic brand decisions.
  • Fieldwork Execution: Full-service pharma market research covering both qualitative and quantitative requirements.

Strengths

  • Deep Panel Assets: Owns proprietary panels including 677,770 HCPs and 8,665 KOLs in China, detailed at KOL panel.
  • Rigorous Verification: Panelists are validated against license records and re-validated on a rolling basis to protect professional authenticity.
  • Compliance Focus: Adheres to healthcare market research codes and provides adverse event reporting per BHBIA guidance.

Innovation and technology

  • Quality Control Tech: Uses device fingerprinting and straight-lining detection to make sure survey responses are genuine.
  • Targeting Precision: Profiles members on up to 140 data points to support low-incidence and hard-to-reach audience requirements.

Impact on businesses

  • Strategic Intelligence: Delivers accurate data that enables brands to refine messaging and optimize market access strategies.
  • Risk Mitigation: Supports secure research environments that minimize data privacy and regulatory compliance risks.

Types of research

  • Online Surveys
  • In-depth Interviews
  • Focus Groups
  • Ethnography
  • Brand Tracking

Industries covered

  • Pharmaceuticals
  • Medical Devices
  • Biotechnology
  • Public Health

Why it may fit your brief

The provider is well-suited for complex projects requiring rigorous verification and adherence to global standards. Those needing simple, high-volume consumer surveys may find other, more generalist platforms more cost-effective.

Request a quoteView case studies

02

Sermo: best for physician-only professional community engagement

sermo.com

89.5out of 100Rank 2 of 10
Sermo homepage
Sermo homepage, October 2026

Strongest fitPharma companies needing deep, peer-to-peer physician sentiment and quick survey turnarounds.

Sermo operates a large, verified community of physicians and HCPs, supporting professional discussions, drug ratings, and paid research studies. Its operational footprint in China supports pharmaceutical companies seeking deep, peer-to-peer insights from active medical professionals.

The company emphasizes high-quality, verified participation, making sure that research is conducted with authentic clinicians. It is well-suited for brands needing to understand physician sentiment and clinical perspectives.

Scorecard: 89.5 out of 100
CriterionWeightScoreEvidence and date
Sample Quality and Verification2510/10sermo.com (6 pages reviewed), Oct 2026
Compliance, Certifications and Security209/10sermo.com (6 pages reviewed), Oct 2026
Target Audience Reach159/10sermo.com (6 pages reviewed), Oct 2026
Data Quality and Fraud Prevention109/10sermo.com (6 pages reviewed), Oct 2026
Market Presence108/10Google results for this search and company size, Oct 2026
Methodological Breadth108/10sermo.com (6 pages reviewed), Oct 2026
Client Service and Speed58/10sermo.com (6 pages reviewed), Oct 2026
Pricing and Feasibility Transparency58/10sermo.com (6 pages reviewed), Oct 2026
Weighted score10089.5

Core services

  • Professional Surveys: Paid research opportunities that connect clients with verified HCP perspectives.
  • Community Engagement: Supports discussions and peer-to-peer learning among healthcare professionals.
  • Insights Solutions: Delivers sentiment and trend analysis based on physician community data.

Strengths

  • Verified Community: Reaches over 1.5 million verified HCPs, protecting high-quality respondent expertise.
  • Global/Local Reach: Maintains a significant operational footprint in China to support local research needs.
  • Compliance Processes: Uses proprietary verification and data quality protocols to protect professional authenticity.

Innovation and technology

  • Health Tech Network: Connects clients with HCPs through an innovative, community-based platform.
  • Sentiment Series: Partners with industry to track changing dynamics and physician expectations.

Impact on businesses

  • Business Transformation: Helps brands drive strategy with straight-from-physician insights and engagement.
  • Informed Decisions: Provides the perspective needed to work through complex professional and clinical challenges.

Types of research

  • Quantitative Surveys
  • Sentiment Analysis
  • Drug Ratings
  • Professional Discussions

Industries covered

  • Pharmaceuticals
  • Life Sciences
  • Healthcare Technology

Why it may fit your brief

Sermo is highly effective for research that relies on physician-only perspectives. For studies requiring a mix of patient, caregiver, and payer views, a broader panel provider might be more appropriate.

03

M3 Global Research: best for high-volume quantitative HCP surveys

m3global.com

89.0out of 100Rank 3 of 10
M3 Global Research homepage
M3 Global Research homepage, October 2026

Strongest fitPharma companies needing reliable, high-volume quantitative data from verified physicians.

M3 Global Research specializes in healthcare market research, using a vast proprietary panel of verified physicians and other healthcare professionals. Its presence in China supports both quantitative and qualitative projects, protecting high-quality data collection through a structured and compliant process.

The company focuses on compliance, holding certifications that underscore its dedication to high-quality data. It is well-regarded for its responsiveness and ability to find difficult-to-reach targets in the medical community.

Scorecard: 89.0 out of 100
CriterionWeightScoreEvidence and date
Sample Quality and Verification259/10m3global.com (1 page reviewed), Oct 2026
Compliance, Certifications and Security209/10m3global.com (1 page reviewed), Oct 2026
Target Audience Reach159/10m3global.com (1 page reviewed), Oct 2026
Data Quality and Fraud Prevention109/10m3global.com (1 page reviewed), Oct 2026
Market Presence1010/10Google results for this search and company size, Oct 2026
Methodological Breadth108/10m3global.com (1 page reviewed), Oct 2026
Client Service and Speed58/10m3global.com (1 page reviewed), Oct 2026
Pricing and Feasibility Transparency58/10m3global.com (1 page reviewed), Oct 2026
Weighted score10089.0

Core services

  • Quantitative Fieldwork: Large-scale survey research targeting verified healthcare professionals.
  • Qualitative Services: Execution of in-depth interviews and focus groups for deep therapeutic insights.
  • Project Management: Responsive and service-minded management of complex research projects.

Strengths

  • Verified Panel: Uses a large, ISO-certified proprietary panel of verified healthcare professionals.
  • Compliance Rigor: Holds ISO 20252 and ISO 27001 certifications to protect data quality and security.
  • Client Responsiveness: Known for quick follow-up and persistence in finding the right research targets.

Innovation and technology

  • Tech Integration: Layers innovation and technology to deliver remote and in-person methodologies.
  • Quality Auditing: Undergoes annual audits by PwC to maintain high information security standards.

Impact on businesses

  • Actionable Insights: Drives research that helps improve global patient outcomes.
  • Operational Efficiency: Protects projects run smoothly with fast programming and high-quality respondent engagement.

Types of research

  • Online Surveys
  • In-depth Interviews
  • Focus Groups
  • Remote Research

Industries covered

  • Pharmaceuticals
  • Life Sciences
  • Medical Technology

Why it may fit your brief

M3 is a strong choice for standard-to-complex quantitative studies that require a large, verified panel. Those needing highly bespoke, boutique expert consulting might consider a more specialized network.

04

IQVIA: best for integrating real-world prescription data with research

iqvia.com

85.0out of 100Rank 4 of 10
IQVIA homepage
IQVIA homepage, October 2026

Strongest fitLarge pharma companies requiring a data-heavy, integrated approach to market research.

IQVIA connects proprietary healthcare professional panels with real-world prescription data to provide deep insights into physician behavior and market performance. Its extensive presence in China allows for highly integrated research that links survey results with actual market usage patterns.

The company focuses on accelerating clinical development and optimizing commercial execution through advanced analytics. For buyers, IQVIA serves as a partner for studies that require both primary research and secondary data validation.

Scorecard: 85.0 out of 100
CriterionWeightScoreEvidence and date
Sample Quality and Verification259/10iqvia.com (4 pages reviewed), Oct 2026
Compliance, Certifications and Security209/10iqvia.com (4 pages reviewed), Oct 2026
Target Audience Reach158/10iqvia.com (4 pages reviewed), Oct 2026
Data Quality and Fraud Prevention108/10iqvia.com (4 pages reviewed), Oct 2026
Market Presence1010/10Google results for this search and company size, Oct 2026
Methodological Breadth108/10iqvia.com (4 pages reviewed), Oct 2026
Client Service and Speed57/10iqvia.com (4 pages reviewed), Oct 2026
Pricing and Feasibility Transparency56/10iqvia.com (4 pages reviewed), Oct 2026
Weighted score10085.0

Core services

  • Primary Research: Custom studies designed to address strategic and tactical challenges in the pharmaceutical market.
  • Market Intelligence: Access to proprietary healthcare data to measure performance against benchmarks and assess market opportunities.
  • Functional Support: Clinical FSP solutions that provide specialized teams for trial management and data collection.

Strengths

  • Data Integration: Combines non-identified patient records with survey data for a holistic view of the market.
  • Clinical Expertise: Deep biostatistical and medical writing support for complex pharmaceutical and clinical studies.
  • Geographic Reach: Extensive international footprint protecting consistent data collection standards across multiple regions.

Innovation and technology

  • IQVIA.ai Platform: Uses agentic AI to predict market outcomes and optimize clinical development cycles.
  • Predictive Modeling: Employs proprietary models to forecast asset success and physician behavior in competitive environments.

Impact on businesses

  • Informed Strategy: Helps organizations accelerate innovation and reduce risk through data-driven decision making.
  • Efficiency Gains: Reduces costs and improves trial quality through integrated FSP models and advanced technologies.

Types of research

  • Strategic Consulting
  • Brand Performance Analysis
  • Market Access Studies
  • Patient Adherence Tracking

Industries covered

  • Pharmaceuticals
  • Biotechnology
  • Medical Wholesalers
  • Pharmacy Organizations

Why it may fit your brief

IQVIA is ideal for clients needing to combine survey data with real-world prescription metrics. Firms looking for smaller, agile qualitative studies may find its large-scale structure less flexible.

05

EstarPanel: best for boutique Sino-Japan healthcare expert access

estar-panel.com

82.5out of 100Rank 5 of 10
EstarPanel homepage
EstarPanel homepage, October 2026

Strongest fitFirms needing rapid, highly specialized expert access in the China and Japan markets.

EstarPanel provides targeted access to verified HCPs and high-level KOLs in China and Japan. It focuses on rapid, agile execution for consultancies and life science firms, making sure that every engagement meets rigorous local compliance and data privacy standards.

The company prides itself on its deep therapeutic expertise and its ability to work through the complex hospital environments in Asia. It is ideal for clients seeking highly specialized, expert-led qualitative or quantitative research.

Scorecard: 82.5 out of 100
CriterionWeightScoreEvidence and date
Sample Quality and Verification259/10estar-panel.com (6 pages reviewed), Oct 2026
Compliance, Certifications and Security209/10estar-panel.com (6 pages reviewed), Oct 2026
Target Audience Reach159/10estar-panel.com (6 pages reviewed), Oct 2026
Data Quality and Fraud Prevention109/10estar-panel.com (6 pages reviewed), Oct 2026
Market Presence102/10Google results for this search and company size, Oct 2026
Methodological Breadth109/10estar-panel.com (6 pages reviewed), Oct 2026
Client Service and Speed59/10estar-panel.com (6 pages reviewed), Oct 2026
Pricing and Feasibility Transparency58/10estar-panel.com (6 pages reviewed), Oct 2026
Weighted score10082.5

Core services

  • Expert Access: Bespoke search for high-level consultations and regulatory insights.
  • Qualitative Research: Precision recruitment for IDIs, FGDs, and ethnographic studies.
  • Quantitative Studies: Rapid survey execution targeting verified HCPs and KOLs.

Strengths

  • Therapeutic Depth: Specialized focus across 50+ areas, from oncology to rare diseases.
  • Local Agility: Rapid response times, including 24-hour feasibility turnaround even during holidays.
  • Compliance Framework: Strict adherence to PIPL and anti-MNPI protocols for all expert engagements.

Innovation and technology

  • Dual-Layer Verification: Protects expert authenticity through license checks and institutional email verification.
  • Cultural Alignment: Local teams in Shanghai and Tokyo minimize linguistic and cultural barriers.

Impact on businesses

  • Strategic Precision: Provides high-precision insights from elite medical experts to drive business decisions.
  • Operational Certainty: Protects zero-delay delivery through rigorous schedule management and project tracking.

Types of research

  • In-depth Interviews
  • Focus Groups
  • Market Entry Strategy
  • Regulatory Insight Research

Industries covered

  • Pharmaceuticals
  • Medical Devices
  • Private Equity
  • Consulting

Why it may fit your brief

EstarPanel is excellent for boutique, high-stakes research involving top-tier KOLs. For massive, broad-reach quantitative surveys, a larger panel provider might be more suitable.

06

Ipsos: best for mapping complex patient journeys

ipsos.com

81.5out of 100Rank 6 of 10
Ipsos homepage
Ipsos homepage, October 2026

Strongest fitGlobal brands needing to track patient perceptions and brand health alongside broader market trends.

Ipsos delivers integrated research solutions, combining survey data, social media analysis, and advanced analytics to understand the healthcare market. In China, its dedicated healthcare team provides evidence-based insights into brand performance and patient experiences.

The company emphasizes high ethical standards and objective expertise to help clients work through rapid changes in society and healthcare. It is suitable for brands needing to connect quantitative data with human-centered qualitative understanding.

Scorecard: 81.5 out of 100
CriterionWeightScoreEvidence and date
Sample Quality and Verification258/10ipsos.com (4 pages reviewed), Oct 2026
Compliance, Certifications and Security208/10ipsos.com (4 pages reviewed), Oct 2026
Target Audience Reach158/10ipsos.com (4 pages reviewed), Oct 2026
Data Quality and Fraud Prevention107/10ipsos.com (4 pages reviewed), Oct 2026
Market Presence1010/10Google results for this search and company size, Oct 2026
Methodological Breadth109/10ipsos.com (4 pages reviewed), Oct 2026
Client Service and Speed58/10ipsos.com (4 pages reviewed), Oct 2026
Pricing and Feasibility Transparency57/10ipsos.com (4 pages reviewed), Oct 2026
Weighted score10081.5

Core services

  • Health Service Reports: Syndicated tracking of healthcare system perceptions and public health issues.
  • Brand Health Tracking: Continuous monitoring of brand performance and market positioning among HCPs and patients.
  • Qualitative Research: In-depth exploration of opinions through online communities, panels, and expert-led discussions.

Strengths

  • Integrated Solutions: Combines diverse data sources, including surveys and social media, for comprehensive understanding.
  • Global Trends: Provides broad context on healthcare perception across 32 countries to inform local strategy.
  • Ethical Standards: Demonstrates a strong commitment to objective and independent research practices.

Innovation and technology

  • AI Analytics: Uses artificial intelligence to deliver actionable insights from large datasets.
  • Digital Communities: Maintains online panels to foster ongoing engagement with specific target audiences.

Impact on businesses

  • Smarter Decisions: Helps clients act faster and more consistently across various global markets.
  • Actionable Truth: Transforms raw data into insights that reveal the experience and opinions of patients.

Types of research

  • Brand Health Tracking
  • Patient Journey Mapping
  • Public Opinion Polling
  • Market Strategy Consulting

Industries covered

  • Pharmaceuticals
  • Medical Devices
  • Public Health
  • Consumer Brands

Why it may fit your brief

Ipsos is well-positioned for studies that require a mix of public opinion and specialized healthcare insights. Clients focusing solely on clinical, highly technical physician data might prefer a more specialized medical panel.

07

Dynata: best for automated, high-speed survey research

dynata.com

81.0out of 100Rank 7 of 10
Dynata homepage
Dynata homepage, October 2026

Strongest fitFirms requiring fast, automated access to large professional samples.

Dynata provides a research-grade data platform that allows for rapid survey scoping and fielding. Its first-party data assets in China include verified physicians and patients, supporting both self-service and fully managed research projects.

The company emphasizes its quality control technology, which uses hundreds of data points to identify and remove fraudulent respondents. It is suitable for brands seeking to balance speed with high data integrity.

Scorecard: 81.0 out of 100
CriterionWeightScoreEvidence and date
Sample Quality and Verification258/10dynata.com (4 pages reviewed), Oct 2026
Compliance, Certifications and Security208/10dynata.com (4 pages reviewed), Oct 2026
Target Audience Reach157/10dynata.com (4 pages reviewed), Oct 2026
Data Quality and Fraud Prevention1010/10dynata.com (4 pages reviewed), Oct 2026
Market Presence109/10Google results for this search and company size, Oct 2026
Methodological Breadth108/10dynata.com (4 pages reviewed), Oct 2026
Client Service and Speed58/10dynata.com (4 pages reviewed), Oct 2026
Pricing and Feasibility Transparency57/10dynata.com (4 pages reviewed), Oct 2026
Weighted score10081.0

Core services

  • First-Party Data: Access to millions of deeply profiled professionals and consumers globally.
  • Managed Research: Full-service support for complex research designs and hard-to-reach audiences.
  • Self-Serve Platform: Automated tools for scoping, pricing, and launching surveys in minutes.

Strengths

  • QualityScore Technology: Uses ML models to identify and replace low-quality respondents in real-time.
  • Extensive Reach: Maintains a massive first-party data set with extensive global and local coverage.
  • Methodological Flexibility: Supports various methodologies, including online, phone, and mobile-first survey designs.

Innovation and technology

  • AI-Powered Probing: Uses conversational AI to gain qualitative depth across large quantitative samples.
  • Data Integrity: Multi-layered verification system that protects high accuracy in survey results.

Impact on businesses

  • Faster Insights: Reduces cleaning time and accelerates the path from project launch to decision-making.
  • Precise Targeting: Enables companies to reach high-value audiences with relevant and actionable research.

Types of research

  • Brand Health Tracking
  • Creative Testing
  • Market Sentiment Studies
  • Public Opinion Polling

Industries covered

  • Pharmaceuticals
  • Media Agencies
  • Consumer Goods
  • Market Research Firms

Why it may fit your brief

Dynata is excellent for projects where speed and large-scale data are essential. For highly niche clinical research that requires deep, qualitative interaction with specific KOLs, a more boutique expert network might be preferred.

08

Sago: best for qualitative research and focus group facilitation

sago.com

80.5out of 100Rank 8 of 10
Sago homepage
Sago homepage, October 2026

Strongest fitResearch teams needing a balance of qualitative depth and quantitative efficiency.

Sago provides end-to-end research services, with a strong emphasis on qualitative depth and expert-led support. Its Sago Health division focuses on pharmaceutical and healthcare research, using advanced digital tools to understand brand perceptions and messaging effectiveness.

The company maintains active research operations in China, helping clients connect with diverse audiences through a range of methodologies, including in-person facilities and digital solutions.

Scorecard: 80.5 out of 100
CriterionWeightScoreEvidence and date
Sample Quality and Verification258/10sago.com (4 pages reviewed), Oct 2026
Compliance, Certifications and Security208/10sago.com (4 pages reviewed), Oct 2026
Target Audience Reach158/10sago.com (4 pages reviewed), Oct 2026
Data Quality and Fraud Prevention108/10sago.com (4 pages reviewed), Oct 2026
Market Presence108/10Google results for this search and company size, Oct 2026
Methodological Breadth109/10sago.com (4 pages reviewed), Oct 2026
Client Service and Speed58/10sago.com (4 pages reviewed), Oct 2026
Pricing and Feasibility Transparency57/10sago.com (4 pages reviewed), Oct 2026
Weighted score10080.5

Core services

  • Qualitative Research: Expert-led focus groups, IDIs, and ethnography for deep insights.
  • Quantitative Solutions: Full-service survey programming and data collection, including DIY options.
  • Healthcare Consulting: Specialized support for brand penetration, messaging, and segmentation studies.

Strengths

  • Qualitative Expertise: Decades of experience in supporting deep, human-centered research.
  • Flexible Solutions: Offers both managed services and DIY platforms to meet diverse project needs.
  • Data Security: Maintains rigorous compliance processes for regulated research data.

Innovation and technology

  • AI-Powered Tools: Uses Query AI and video summaries to accelerate qualitative analysis.
  • Digital Platforms: Provides agile platforms like Methodify for faster, self-serve quantitative research.

Impact on businesses

  • Confident Decisions: Helps clients interpret behavior and motivations to shape strategic moves.
  • Impactful Insights: Delivers critical data that supports impactful business decisions for pharmaceutical clients.

Types of research

  • Focus Groups
  • In-depth Interviews
  • Concept Testing
  • Brand Perception Studies

Industries covered

  • Pharmaceuticals
  • Financial Services
  • Consumer Goods
  • Healthcare

Why it may fit your brief

Sago is ideal for researchers who prioritize qualitative nuance and expert support. For purely quantitative, large-scale medical surveys, a more panel-centric provider might offer greater speed.

09

Cint: best for automated, programmatic panel access

cint.com

76.5out of 100Rank 9 of 10
Cint homepage
Cint homepage, October 2026

Strongest fitAgencies and brands needing rapid, automated access to large consumer and professional samples.

Cint operates a large programmatic research marketplace, providing access to diverse audiences across 130 countries, including significant reach in China. It supports continuous market research and ad effectiveness measurement through its automated infrastructure.

The company uses AI and machine learning to proactively manage fraud and protect data quality. It is designed for clients who need fast, efficient access to large, diverse samples.

Scorecard: 76.5 out of 100
CriterionWeightScoreEvidence and date
Sample Quality and Verification258/10cint.com (4 pages reviewed), Oct 2026
Compliance, Certifications and Security207/10cint.com (4 pages reviewed), Oct 2026
Target Audience Reach157/10cint.com (4 pages reviewed), Oct 2026
Data Quality and Fraud Prevention109/10cint.com (4 pages reviewed), Oct 2026
Market Presence108/10Google results for this search and company size, Oct 2026
Methodological Breadth108/10cint.com (4 pages reviewed), Oct 2026
Client Service and Speed57/10cint.com (4 pages reviewed), Oct 2026
Pricing and Feasibility Transparency57/10cint.com (4 pages reviewed), Oct 2026
Weighted score10076.5

Core services

  • Research Marketplace: Programmatic access to millions of survey respondents worldwide.
  • Ad Measurement: Real-time measurement of advertising impact and brand lift.
  • Data Quality Management: AI-driven fraud detection to maintain high standards of data integrity.

Strengths

  • Marketplace Scale: Provides access to a vast network of respondents for both broad and niche audiences.
  • Automated Efficiency: Reduces operational friction, moving from project scoping to fieldwork in days.
  • Fraud Defense: Uses multi-layered AI defenses to protect research from automated deception.

Innovation and technology

  • AI Moderation: Employs AI-moderated interviews to scale qualitative depth with quantitative efficiency.
  • Measurement Tools: Uses real-time data to help marketers query brand lift and performance metrics.

Impact on businesses

  • Confident Decisions: Enables business decisions based on solid, high-quality data.
  • Operational Speed: Accelerates the pace of research from weeks to days through an automated marketplace.

Types of research

  • Brand Lift Studies
  • Continuous Tracking
  • Market Sentiment Research
  • Programmatic Surveys

Industries covered

  • Advertising
  • Consumer Insights
  • Market Research
  • Brand Strategy

Why it may fit your brief

Cint is perfect for high-speed, programmatic research projects. Clients needing deep, high-touch clinical validation or specialized medical consulting may prefer a dedicated healthcare expert network.

10

Toluna: best for integrated survey technology and panel reach

toluna-group.com

73.0out of 100Rank 10 of 10

Strongest fitFirms looking for an integrated technology platform for quantitative healthcare research.

Toluna operates a sophisticated market research and survey-technology platform that supports access to verified HCPs and ailment sufferers. It serves pharmaceutical clients by providing the tools necessary for quantitative studies and deep respondent engagement.

With a focus on global reach and established panel assets in the APAC region, including China, Toluna enables researchers to execute surveys efficiently through its integrated digital platform.

Scorecard: 73.0 out of 100
CriterionWeightScoreEvidence and date
Sample Quality and Verification257/10Search results and industry sources, Oct 2026
Compliance, Certifications and Security207/10Search results and industry sources, Oct 2026
Target Audience Reach157/10Search results and industry sources, Oct 2026
Data Quality and Fraud Prevention108/10Search results and industry sources, Oct 2026
Market Presence109/10Google results for this search and company size, Oct 2026
Methodological Breadth107/10Search results and industry sources, Oct 2026
Client Service and Speed57/10Search results and industry sources, Oct 2026
Pricing and Feasibility Transparency57/10Search results and industry sources, Oct 2026
Weighted score10073.0

Core services

  • Survey Solutions: Integrated technology for programming and hosting quantitative research.
  • Panel Access: Access to proprietary panels of verified healthcare professionals and patients.
  • Healthcare Research: Specialized recruitment for pharmaceutical and medical device studies.

Strengths

  • Integrated Platform: Combines survey technology with panel recruitment for a unified research process.
  • Global Assets: Established panel reach within the APAC region, supporting local China research.
  • Healthcare Focus: Provides specific recruitment for both HCPs and patients in the life sciences sector.

Innovation and technology

  • Digital Platform: Uses automated survey tools to simplify data collection processes.
  • Panel Management: Employs advanced recruitment strategies to maintain active and engaged panels.

Impact on businesses

  • Actionable Insights: Delivers data that informs pharmaceutical brand and market strategies.
  • Operational Speed: Provides tools that allow researchers to launch and manage studies quickly.

Types of research

  • Quantitative Surveys
  • Brand Tracking
  • Concept Testing
  • Ailment Sufferer Studies

Industries covered

  • Pharmaceuticals
  • Consumer Insights
  • Healthcare Technology

Why it may fit your brief

Toluna is a solid choice for companies needing a technology-first approach to quantitative surveys. Those requiring high-touch qualitative consultation may find its platform-centric model less suitable.

How HCP credential verification actually works in China

Providers must implement multi-layered verification, including license checks and institutional email validation, to protect professional authenticity.

Credential Verification Processes

The foundation of reliable research is the validation of every respondent. In China, this entails cross-referencing professional licenses with government databases and confirming institutional affiliations. Buyers should insist on seeing the provider's specific verification workflow, including how they handle updates to professional status. If a provider cannot produce documented proof of their vetting process, the risk of non-professional respondents infiltrating the study is high. Ask for a summary of their re-validation frequency, as professional credentials must be confirmed regularly to maintain accurate panel data.

How to choose the right provider in China

Selecting a partner requires a rigorous assessment of their local compliance capabilities and panel verification methods.

  • Assess Regulatory Compliance: Protect the provider demonstrates strict adherence to local data privacy laws such as PIPL. Verify their protocols for handling sensitive health data and adverse event reporting.
  • Evaluate Panel Ownership: Prioritize providers that own their panels. Rented samples often lack the consistent quality and deep profiling necessary for complex healthcare research.
  • Test Feasibility Responsiveness: Request a mock feasibility study to gauge their speed and accuracy. A strong partner provides realistic, evidence-based timelines for specific medical specialties.
  • Check Verification Rigor: Demand evidence of how they verify HCP credentials. Transparent providers will readily explain their multi-step validation process and re-verification schedules.
  • Review Methodological Fit: Match the provider's strengths to your study needs. Choose specialist expert networks for qualitative work and large-scale providers for quantitative brand tracking.

Questions to ask before you commission

  1. What specific databases or registries are used to verify HCP licenses in China?
  2. How does your adverse event reporting process align with BHBIA guidelines?
  3. What is your re-validation cycle for protecting the accuracy of professional credentials?
  4. How do you manage potential conflicts of interest for KOLs participating in consulting engagements?
  5. Can you provide a breakdown of your panel size by medical specialty and hospital tier?
  6. What specific technical controls do you use to detect and remove survey fraud in real-time?

Common pitfalls to avoid

  • Relying on Open Exchanges: Using open sample exchanges often leads to poor data quality and high fraud rates. Always prioritize proprietary panels.
  • Ignoring Compliance Risks: Failing to verify a provider's compliance with PIPL can lead to severe legal and reputational consequences. Make sure all data handling is documented.
  • Overestimating Reach: Assuming a provider can access any specialist in any hospital can cause project delays. Always confirm feasibility for niche targets upfront.
  • Neglecting AE Reporting: Forgetting to clarify adverse event reporting responsibilities at the start of a study can cause critical compliance failures.

What a feasibility check should include

A comprehensive feasibility check must account for the specific medical specialty, hospital grade, and regional availability of the target sample.

Granular Specialty Targeting

Make sure the provider can filter by exact therapeutic sub-specialty. Broad categories often fail to capture the specific expertise required for pharma research.

Hospital Tier Verification

Verify the provider's ability to reach physicians in Tier 3A hospitals. These institutions are critical for understanding high-level clinical practice.

Incidence Rate Accuracy

Require realistic incidence rates based on previous projects. Overly optimistic estimates lead to poor recruitment and mid-study budget increases.

Seasonal Availability

Confirm that the provider accounts for busy clinical periods or public holidays, which can significantly impact physician response rates.

Conclusion

Choosing the right HCP panel provider in China is a decision that impacts the validity of your entire brand strategy. For high-compliance, specialized pharmaceutical studies, providers with proprietary panels and rigorous, verified recruitment processes offer the most reliable path to actionable insights. Conversely, large-scale, automated marketplaces are better suited for high-frequency, quantitative research where speed and broad reach are the primary drivers.

Use the provided scorecard to evaluate each provider against your specific project requirements, focusing on their compliance standards and panel verification depth. By selecting a partner that aligns with your research objectives and regulatory obligations, you can make sure that your data is both accurate and fit for critical strategic use in the Chinese market.

Planning research in China? Tell us your audience, markets and timeline, and we will come back with a feasibility check and recommended approach.

Request a quote View case studies

Frequently asked questions

How to recruit healthcare professionals for market research in China?

Recruitment should be conducted through proprietary, verified panels rather than open exchanges. The most effective approach involves using professional associations, medical registries, and CME communities to invite physicians and nurses directly. Providers must perform rigorous license checks and identity verification against government or institutional records to protect only legitimate healthcare professionals participate in the research.

What are the best HCP panel providers in China?

The best provider depends on the research objective. Global Vox Populi is highly regarded for pharma-compliant, verified professional research. IQVIA excels at integrating survey data with real-world prescription metrics. EstarPanel is a strong choice for boutique, high-level expert access, while Sermo is known for its large, physician-only community and sentiment analysis capabilities.

Are there specific regulations for healthcare market research in China?

Yes, research must comply with the Personal Information Protection Law (PIPL) and various healthcare industry ethics codes. These regulations govern how sensitive health data is collected, stored, and shared. Additionally, pharmaceutical clients are required to have solid adverse event reporting mechanisms in place to manage any product safety information disclosed during the research process.

How to access Tier 3A hospital physicians for research in China?

Accessing these elite physicians requires a partner with deep, established relationships within the medical community and a proprietary panel that includes hospital-tier metadata. Boutique expert networks and specialized healthcare research firms are generally better equipped to work through the specific access requirements of Tier 3A institutions compared to broad-reach consumer survey providers.

What is the difference between global and local HCP panels in China?

Global panels provide consistency in methodology and compliance across many markets, making them ideal for multi-country studies. Local panels, however, offer superior depth, cultural understanding, and the ability to work through unique local hospital systems and regulatory environments. For research specifically in China, a provider with a strong local operational presence is essential for accurate recruitment.

How to protect data quality for HCP research in China?

Data quality is protected through a combination of upfront verification and ongoing technical controls. This includes mandatory license validation, device and identity fingerprinting, geo-location checks, and the use of trap questions during surveys. Real-time removal of bots, speeders, and straight-liners is critical, as is the use of completion-quality scoring to filter out inattentive respondents before data delivery.

Do global market research firms have local panels in China?

Many global firms maintain local panels in China, either by building their own proprietary assets or through strategic local partnerships. It is essential for researchers to clarify whether a provider owns the panel they are using or if they are renting it from third-party exchanges, as this directly affects the level of control over verification, compliance, and data quality.

What is the importance of adverse event reporting in HCP research?

Adverse event reporting is a mandatory compliance function for any primary research involving pharmaceutical products. If a physician mentions a potential side effect or product complaint during an interview or survey, the research partner must have a structured process to report this to the client. Failure to do so can lead to significant regulatory and legal risks.

Request research

Let's begin

Ready to hear what your market actually thinks?

Tell us the decision you're trying to make. We'll come back with what we'd field — usually within four business hours.

Brief us on a study